Marshall Wace North America’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-213,359
| Closed | -$52.3M | – | 1349 |
|
|
2021
Q2 | $52.3M | Sell |
213,359
-37,858
| -15% | -$9.27M | 0.22% | 95 |
|
|
2021
Q1 | $66.5M | Sell |
251,217
-25,927
| -9% | -$6.87M | 0.28% | 79 |
|
|
2020
Q4 | $81.3M | Sell |
277,144
-85,318
| -24% | -$25M | 0.37% | 59 |
|
|
2020
Q3 | $85.7M | Sell |
362,462
-85,327
| -19% | -$20.2M | 0.55% | 36 |
|
|
2020
Q2 | $88.9M | Buy |
447,789
+247,111
| +123% | +$49.1M | 0.59% | 36 |
|
|
2020
Q1 | $36.8M | Sell |
200,678
-51,648
| -20% | -$9.48M | 0.28% | 97 |
|
|
2019
Q4 | $42.1M | Sell |
252,326
-38,579
| -13% | -$6.44M | 0.2% | 136 |
|
|
2019
Q3 | $38.1M | Buy |
290,905
+211,148
| +265% | +$27.7M | 0.22% | 113 |
|
|
2019
Q2 | $9.68M | Buy |
+79,757
| New | +$9.68M | 0.06% | 245 |
|
|
2019
Q1 | – | Sell |
-1,124
| Closed | -$132K | – | 1535 |
|
|
2018
Q4 | $132K | Buy |
+1,124
| New | +$132K | ﹤0.01% | 1034 |
|
|
2018
Q2 | – | Sell |
-63,652
| Closed | -$3.84M | – | 1360 |
|
|
2018
Q1 | $3.84M | Sell |
63,652
-144,507
| -69% | -$8.72M | 0.02% | 626 |
|
|
2017
Q4 | $11M | Buy |
208,159
+192,916
| +1,266% | +$10.2M | 0.06% | 356 |
|
|
2017
Q3 | $854K | Sell |
15,243
-101,699
| -87% | -$5.7M | 0.01% | 981 |
|
|
2017
Q2 | $7.37M | Buy |
116,942
+11,821
| +11% | +$745K | 0.05% | 389 |
|
|
2017
Q1 | $5.36M | Buy |
+105,121
| New | +$5.36M | 0.04% | 382 |
|